Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET‐EN), in South African women

Autor: Samkelisiwe Ngcobo, Sinaye Ngcapu, Natasha Samsunder, Jo-Ann S. Passmore, John H. Adamson, Lyle R. McKinnon, Mthobisi M Zondi, Lenine J. P. Liebenberg, Alasdair Leslie, Amanda Mabhula, Salim S. Abdool Karim, Quarraisha Abdool Karim, Nobuhle Nokubonga Mchunu, Katya Govender, Aida Sivro, Refilwe P Molatlhegi
Rok vydání: 2021
Předmět:
Zdroj: American Journal of Reproductive Immunology.
ISSN: 1600-0897
1046-7408
DOI: 10.1111/aji.13411
Popis: PROBLEM Injectable hormonal contraceptives (IHC) have been associated with altered mucosal and systemic milieu which might increase HIV risk, but most studies have focused on DMPA and not NET-EN, despite the growing popularity and lower HIV risk associated with the latter in observational studies. METHOD OF STUDY We used high-performance liquid chromatography in combination with tandem triple quadrupole mass spectrometry (HPLC-LC-MS/MS) to measure steroid hormones in plasma samples of CAPRISA004 study participants. Concentrations of 48 cytokines were measured in the cervicovaginal lavage (CVL) and plasma, and their expression was compared between participants with detectable NET-EN (n = 201) versus non-detectable IHC (n = 90). Each log10 cytokine concentration was tested as an outcome in linear-mixed models, with NET-EN detection as the main explanatory variable. Multivariable models were adjusted for potential confounders. RESULTS In bivariate analysis, detectable NET-EN was associated with reduced cervicovaginal M-CSF (P = 0.008), GM-CSF (P = 0.025) and G-CSF (P = 0.039), and elevated levels MIF (P = 0.008), IL-18 (P = 0.011), RANTES (P = 0.005) and IL-1Rα (P
Databáze: OpenAIRE